Inflammation and Microglia Actions in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2009-08-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11481-009-9165-3PMID 19669893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microglial activation and amyloid deposition in mild cognitive impairment

  2009cited by this paper
• Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology

  2009cited by this paper
• Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

  2008cited by this paper
• Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease

  2008cited by this paper
• Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

  2008cited by this paper
• Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease

  2008influential reference
• Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-Aβ Antibody Administration in PDAPP Mice

  2008influential reference
• Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic

  2008influential reference
• ApoE promotes the proteolytic degradation of Abeta.

  2008influential reference
• GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice

  2008cited by this paper
• Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.

  2008cited by this paper
• Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity

  2008cited by this paper
• Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• NSAID use and dementia risk in the Cardiovascular Health Study*

  2008cited by this paper
• Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

  2008cited by this paper
• Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice

  2008cited by this paper
• Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model

  2008cited by this paper
• Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease

  2008cited by this paper
• Inflammatory changes parallel the early stages of Alzheimer disease.

  2007cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007influential reference
• Immunotherapy as treatment for Alzheimer’s disease

  2007cited by this paper
• Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.

  2007cited by this paper
• In Brief

  2007cited by this paper
• Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model

  2007cited by this paper
• Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine

  2006cited by this paper
• Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease

  2006cited by this paper
• Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.

  2006cited by this paper
• Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics

  2005cited by this paper
• Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia.

  2005cited by this paper
• Retinoic acid inhibits expression of TNF‐α and iNOS in activated rat microglia

  2005cited by this paper
• Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

  2005cited by this paper
• Novel ‘inflammatory plaque’ pathology in presenilin‐1 Alzheimer's disease

  2005cited by this paper
• Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease

  2004cited by this paper
• Dystrophic microglia in the aging human brain

  2004cited by this paper
• Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease

  2004cited by this paper
• Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.

  2004cited by this paper
• Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

  2003cited by this paper
• Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography

  2003cited by this paper
• Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice

  2003cited by this paper
• Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

  2002cited by this paper
• Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

  2002cited by this paper
• Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites

  2002cited by this paper
• Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease.

  2002cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid.

  2001cited by this paper
• Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

  2000cited by this paper
• Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease.

  2000cited by this paper
• Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies.

  2000cited by this paper
• Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy.

  1999cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999cited by this paper
• Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice.

  1999cited by this paper
• Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease.

  1999cited by this paper
• Occurrence of the diffuse amyloid β‐protein (Aβ) deposits with numerous Aβ‐containing glial cells in the cerebral cortex of patients with Alzheimer's disease

  1999cited by this paper
• Enlarged and phagocytic, but not primed, interleukin-1α-immunoreactive microglia increase with age in normal human brain

  1998cited by this paper
• Microglial response to amyloid plaques in APPsw transgenic mice.

  1998cited by this paper
• Microglial activation in early stages of amyloid beta protein deposition.

  1997cited by this paper
• Microglial activation in early stages of amyloid β protein deposition

  1997cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Role of microglia in senile plaque formation.

  1995influential reference
• Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.

  1994cited by this paper
• A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation.

  1991cited by this paper
• Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.

  1990cited by this paper
• Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

  1990cited by this paper
• Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease.

  1990cited by this paper
• Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.

  1990cited by this paper
• Brain microglia constitutively express beta-2 integrins.

  1990cited by this paper
• Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

  1989influential reference
• Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

  1987cited by this paper
• Journal of Neuroinflammation Exercise Alters the Immune Profile in Tg2576 Alzheimer Mice toward a Response Coincident with Improved Cognitive Performance and Decreased Amyloid

  year unknowninfluential reference
• Journal of Neuroinflammation Expression Profiles for Macrophage Alternative Activation Genes in Ad and in Mouse Models of Ad

  year unknowncited by this paper

• Microglial activation is raised in preclinical Alzheimer’s disease and associated with covert memory impairment

  2026cites this paper
• Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways

  2025cites this paper
• Dexmedetomidine suppresses microglial activation in postoperative cognitive dysfunction via the mmu-miRNA-125/TRAF6 signaling axis

  2025cites this paper
• Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease

  2025influential citation
• Pregnancy zone protein, a potential research target in multiple diseases.

  2024cites this paper
• The Association Between Cardiovascular Disease and Dementia: A Review of Trends in Epidemiology, Risk Factors, Pathophysiologic Mechanisms, and Clinical Implications.

  2023cites this paper
• Aurantiamide suppresses the activation of NLRP3 inflammasome to improve the cognitive function and central inflammation in mice with Alzheimer's disease

  2023cites this paper
• Bioinformatic analysis of biological pathways in coronary heart disease and Alzheimer’s disease

  2023cites this paper
• Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease

  2022cites this paper
• Chronic Ethanol Causes Persistent Increases in Alzheimer’s Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment

  2022cites this paper
• Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions

  2022cites this paper
• Dexmedetomidine Alleviates LPS-Induced Neuronal Dysfunction by Modulating the AKT/ GSK-3 β /CRMP-2 Pathway in Hippocampal Neurons

  2021cites this paper
• Dexmedetomidine Alleviates LPS-Induced Neuronal Dysfunction by Modulating the AKT/GSK-3β/CRMP-2 Pathway in Hippocampal Neurons

  2021cites this paper
• The persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics.

  2021cites this paper
• A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-β Oligomers in Mice

  2021cites this paper
• Quantitative analysis of the focused ultrasound-induced blood-brain barrier opening with applications in neurodegenerative disorders

  2020cites this paper
• Human-Derived Brain Models: Windows into Neuropsychiatric Disorders and Drug Therapies

  2020cites this paper
• Getting to the Heart of Alzheimer Disease

  2019cites this paper
• NDT_A_203103 1343..1354

  2019influential citation
• Unilateral Focused Ultrasound-Induced Blood-Brain Barrier Opening Reduces Phosphorylated Tau from The rTg4510 Mouse Model

  2019cites this paper
• What are the links between hypoxia and Alzheimer’s disease?

  2019influential citation
• Hypoxia and alzheimer's disease: the processing of amyloid precursor protein and the role of prolyl-hydroxylase 3 in microglia.

  2018cites this paper
• Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model

  2018cites this paper
• K ynurenines, neuro d eg en eratio n and A lzh e im e r’s disease

  2018cites this paper
• Pattern recognition receptors mediate pro‐inflammatory effects of extracellular mitochondrial transcription factor A (TFAM)

  2018cites this paper
• Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin

  2017cites this paper
• Intramembrane attenuation of the TLR4-TLR6 dimer impairs receptor assembly and reduces microglia-mediated neurodegeneration

  2017cites this paper
• Brain insulin signaling in Alzheimer's disease

  2017cites this paper
• Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors

  2017cites this paper
• APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease

  2016cites this paper
• Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity.

  2016cites this paper
• Microglia in Alzheimer's disease: the good, the bad and the ugly.

  2016cites this paper
• High-Fat and Cholesterol Intake Affects Brain Homeostasis and Could Accelerate the Development of Dementia: A Systemic View

  2016cites this paper
• Immune responses to amyloid beta and post-translationally modified variants

  2016cites this paper
• Automated brain mapping to evaluate the relationship between neurodegeneration, cerebral small vessel disease and structural covariance network disruption in Alzheimer's disease

  2016cites this paper
• Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease.

  2015cites this paper
• Pregnancy Zone Protein is Increased in the Alzheimer’s Disease Brain and Associates with Senile Plaques

  2015cites this paper
• Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease

  2015cites this paper
• Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.

  2015cites this paper
• Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer’s disease

  2015cites this paper
• Alzheimer's Disease and the Immune System

  2015influential citation
• GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.

  2015cites this paper
• Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation

  2015influential citation
• Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

  2014cites this paper
• Mitochondrial transcription factor a (TFAM): a novel brain intercellular signaling molecule and microglial activator

  2014cites this paper
• Adiponectin and Alzheimer's disease: Is there a link?

  2014cites this paper
• Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.

  2013cites this paper
• Treatment with D3 Removes Amyloid Deposits, Reduces Inflammation, and Improves Cognition in Aged AβPP/PS1 Double Transgenic Mice

  2013cites this paper
• Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model.

  2012cites this paper
• Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s disease

  2012cites this paper
• Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway.

  2012cites this paper
• Adenosine Augments IL-10 Production by Microglial Cells through an A2B Adenosine Receptor-Mediated Process

  2012cites this paper
• Akebia Saponin D attenuates amyloid β-induced cognitive deficits and inflammatory response in rats: involvement of Akt/NF-κB pathway.

  2012cites this paper
• Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia

  2012cites this paper
• Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration

  2012cites this paper
• Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

  2012cites this paper
• Interaction between Amyloid-β Pathology and Cortical Functional Columnar Organization

  2012cites this paper
• Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia.

  2012cites this paper
• Receptor-Mediated Process Adenosine 2B Microglial Cells through an A Adenosine Augments IL-10 Production by

  2011cites this paper
• P2‐516: An Abeta vaccine for canine cognitive dysfunction syndrome and Alzheimer's disease

  2011cites this paper
• Novel Anti-Inflammatory Compound SEN1176 Alleviates Behavioral Deficits Induced Following Bilateral Intrahippocampal Injection of Aggregated Amyloid-β1-42

  2011cites this paper
• Toll-like receptors are key players in neurodegeneration.

  2011influential citation
• Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice

  2011cites this paper
• Cognitive impairment following high fat diet consumption is associated with brain inflammation.

  2010cites this paper
• Inflammation, microglia, and Alzheimer's disease.

  2010cites this paper
• Low energy laser light (632.8 nm) suppresses amyloid-β peptide-induced oxidative and inflammatory responses in astrocytes.

  2010cites this paper
• Kynurenines, neurodegeneration and Alzheimer’s disease

  2010cites this paper
• Microglia in Central Nervous System Diseases

  2009cites this paper